SAN DIEGO, May 16, 2016 (GLOBE NEWSWIRE) -- Entra Health is teaming up with Rimidi Diabetes to battle diabetes in a whole new way. The pair will exhibit together at the 2016 American Telemedicine Association (ATA) Annual Conference in Minneapolis, May 14-17, 2016. Rimidi, an Atlanta-based digital health firm, is focused on market data analytics and disease management solutions. Entra Health is well known for its Entra360 managed services for diabetes, heart failure and COPD. Both Entra Health and Rimidi serve the healthcare and clinical research markets.
“We are offering connected health technology that integrates Entra Health's remote patient monitoring with Rimidi's advanced analytics to improve patient outcomes and assist providers in making better medical decisions for personalized care,” said Dr. Lucie Ide, Rimidi CEO. “We are pleased to participate in the ATA conference and partner with Entra Health to deliver next generation integrated diabetes management solutions.”
“Entra Health will be unveiling the new entraCare Kit,” said Richard Strobridge, CEO of Entra Health. “The entraCare solution incorporates best-in-class remote patient monitoring modules designed for indication-specific care plans ranging from general health to chronic disease management.”
The entraCare Kit is part of Entra360, a one-stop solution that provides an effective, easy to implement platform for gathering wireless biometric data. Entra360 is effective for both the payer/provider and clinical research market segments. Entra360 is part of expanding efforts by the company to provide easy-to-implement, turnkey products for cloud-based analytics and remote patient monitoring. Attendees can visit both Entra Health and Rimidi in booth 1734.
About Entra Health
Entra Health is an international digital health and IT solutions provider that is focused on cloud-based remote patient monitoring, telehealth, data exchange and analytics. Entra Health’s secure Platform-as-a-Service (PaaS) remote patient monitoring solutions and devices have regulatory approval in 50 countries. The company is a leader in wireless biometric data collection for clinical trials. For more information: www.entrahealth.com or call 877-458-2646.
Rimidi is an Atlanta-based, woman-led digital health company bringing to market data analytics and disease management solutions. Its flagship product, Diabetes+Me™, is a software solution focused on empowering quality diabetes care for healthcare organizations and providers. Rimidi has received funding from SOURCE, a partnership between the Hitachi Foundation, Investor’s Circle and Village Capital, as well at the Sorenson Foundation. The company also received funding from the JumpFund, whose mission is to invest women’s capital in female-led companies with growth potential, and Cox Enterprises. In January 2016, Rimidi was recognized as a top three healthcare technology by ACT The App Association, and a top 10 innovative product by the Technology Association of Georgia. For more information, visit rimidi.com.
Media Contact Bruce Ahern, Chief Marketing Officer Entra Health Systems 877-458-2646 x709 email@example.com